Expanded criteria for active surveillance in prostate cancer: a review of the current data

Over the last ten years, active surveillance (AS) has become increasingly utilized for patients with low-risk prostate cancer. Appropriately selected AS patients have a 10-year prostate cancer-specific mortality (PCSM) approaching 99%. Therefore, some institutions have expanded the inclusion criteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Cameron, Fam, Mina M., Davies, Benjamin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911537/
https://www.ncbi.nlm.nih.gov/pubmed/29732280
http://dx.doi.org/10.21037/tau.2017.08.23

Ejemplares similares

Ejemplares similares